Résultats de la recherche - 44 results
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
meeting the definition of immunocompromised conditions (from January 24, 2022) and to people who had received the Jcovden vaccine (Johnson&Johnson®) as a primary COVID-19 vaccination schedule (from ...
Epidemiology of COVID-19 mortality in Belgium from wave 1 to wave 7 (March 2020 – 11 September 2022)
surveillance of COVID-19 mortality, the observations on the first seven waves combined of the epidemic in Belgium (01/03/2020 – 11/09/2022) are as follows: Waves 66.8% of the COVID-19 deaths occurred during the ...
EBoD-FL. Guidelines for mapping the environmental burden of disease in Flanders
according to a coherent framework. To tackle this objective, the disease burden attributable to environmental stressors is estimated using comparative risk assessment (CRA). As this method determines the ...
PT-2022-NRL-TE-FASFC “Determination of As, Asi, Cd, Pb and Hg in unrefined salts”
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Gregoire Rondelet; Karlien Cheyns Source: p.26 (2022) Health Topics: Food consumption and food safety Consommation et sécurité alimentaires Voedselconsumptie en –ve ...
Monitoring HIV pre-exposure prophylaxis programmes in the EU/EEA
calls for relevant and actionable data that are feasible to collect as well. In addition, a streamlined approach to PrEP monitoring across EU / EEA countries is required to paint a more detailed picture ...
Surveillance of COVID-19 mortality in Belgium, epidemiology and methodology during 1st and 2nd wave (March 2020- 14 February 2021)
classification, type of place of death, type of place of residence (e.g. living in a NH), postal code of the place of death and residence. Continuous improvements as regards the data collection resulted in ...
Annual Report Belgian Cystic Fibrosis Registry 2018
patients. The patient population continues to record an improvement in lung function expressed as the mean percentage of predicted FEV1. Among the F508 del homozygous patients, 27.6% of the children and 3.5% ...
Annual Report Belgian Cystic Fibrosis Registry 2017
expressed as the mean percentage of predicted FEV1. Among the F508 del homozygous patients, 38.0% of the children and 5.1% of the adults had FEV1 ≥ 90.0% of predicted in 1998 compared to 52.9% and 7.0% in ...
Point Prevalence Study of Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute-Care Hospitals: Results of the ECDC PPS 2017
(95% CI: 27.3-29.0%). Medical prophylaxis, surgical prophylaxis and treatment of HAI s were reported as indication in 6.2%, 13.5% and 24.2% of the prescribed antimicrobial agents (N=4103), respectively. ...
Annual report Belgian Cystic Fibrosis Registry 2016
percentile has also been declining over the years. The above suggests better nutritional management in the patients. The patient population continues to record an improvement in lung function expressed as the ...